321
Participants
Start Date
February 28, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Verteporfin Photodynamic Therapy
After a 10-minute intravenous infusion of verteporfin at a dose of 6 mg/m\^2 body surface area, verteporfin was activated by light application of 50 J/cm\^2 (Standard Fluence rate) or 25 J/cm\^2 (Reduced Fluence rate) to the study eye, begun 15 minutes after the start of the infusion.
Ranibizumab
Ranibizumab 0.5 mg administered as an intravitreal injection.
Verteporfin Placebo
To maintain masking, as a placebo for verteporfin photodynamic therapy, patients were administered a 10-minute intravenous infusion of 5% dextrose solution, followed by light application of 50 J/cm\^2 to the study eye, begun 15 minutes after the start of infusion.
Ranibizumab Placebo
To maintain masking, patients in the combination groups received sham intravitreal injections whenever retreatment with active Ranibizumab was not warranted based on the retreatment algorithm.
Novartis Investigative Site, Lynbrook
Novartis Investigative Site, Rochester
Novartis Investigative Site, West Mifflin
Novartis Investigative Site, Pittsburgh
Novartis Investigative Site, Baltimore
Novartis Investigative Site, Fairfax
Novartis Investigative Site, Richmond
Novartis Investigative Site, West Columbia
Novartis Investigative Site, Kingsport
Novartis Investigative Site, Knoxville
Novartis Investigative Site, Lexington
Novartis Investigative Site, Paducah
Novartis Investigative Site, Beachwood
Novartis Investigative Site, Cleveland
Novartis Investigative Site, Cincinnati
Novartis Investigative SIte, Royal Oak
Novartis Investigative Site, Grand Rapids
Novartis Investigative Site, Williamsburg
Novartis Investigative Site, Iowa City
Novartis Investigative Site, Milwaukee
Novartis Investigative Site, Rapid City
Novartis Investigative Site, St Louis
Novartis Investigative Site, Independence
Novartis Investigative Site, Wichita
Novartis Investigative Site, Houston
Novartis Investigative Site, Austin
Novartis Investigative Site, Denver
Novartis Investigative Site, Tucson
Novartis Investigative Site, Beverly Hills
Novartis Investigative Site, Santa Ana
West Coast Retina Medical Group Inc. - 185 Berry St. Suite 130, San Francisco
Novartis Investigative Site, Oakland
Novartis Investigative Site, Sacramento
Novartis Investigative Site, ‘Aiea
Novartis Investigative Site, Pasadena
Novartis Investigative Site, Toms River
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Halifax
Ivey Eye Institute, Dr. Thomas Sheidow, London
Novartis Investigative Site, London
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Montreal
Lead Sponsor
Novartis
INDUSTRY